|
Market Closed -
Hong Kong S.E.
04:08:09 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 1.060 HKD | -1.40% |
|
+0.47% | -30.26% |
| 09-10 | Lee's Pharma Licenses Cancer Drug OC-3 From 1cBio; Shares Plummet 4% | MT |
| 08-31 | Lee's Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Chart: Technical Analysis
Hong Kong S.E.HKD
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 950 | Delayed | |
Deutsche Boerse AG
| L1PA | Delayed | |
|
Börse Stuttgart
| L1PA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 1.135 | 1.375 | 1.36 |
| Spread/Res. | -6.61% | -22.91% | -22.06% |
| Spread/Supp. | +0.47% | +2.91% | +1.92% |
| Support | 1.055 | 1.03 | 1.04 |
- Stock Market
- Stocks
- 950 Stock
- Charts Lee's Pharmaceutical Holdings Limited
Select your edition
All financial news and data tailored to specific country editions
